Medical treatment of tuberculosis: antecedents and effects of bacterial resistance; U.S. Public Health Service cooperative clinical investigation.
D010131:Aminosalicylic Acid / Q000627:therapeutic use*; D001424:Bacterial Infections; D009525:Niacin; D009539:Nicotinic Acids / Q000627:therapeutic use*; D013307:Streptomycin / Q000627:therapeutic use*; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary / Q000628:therapy*; D014481:United States; D014492:United States Public Health Service
D009539:Nicotinic Acids; D009525:Niacin; D010131:Aminosalicylic Acid; D013307:Streptomycin
NICOTINIC ACID ISOMERS/therapeutic use; PARA-AMINOSALICYLIC ACID/therapeutic use; STREPTOMYCIN/therapeutic use; TUBERCULOSIS, PULMONARY/therapy